Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
Hs 578T
TNBC
Basal B
Cetuximab
EGFR
ErbB
7861.018
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.8485
MDA-MB-468
TNBC
Basal A
AG1478
EGFR
ErbB
7905.016
uM
inf
inf
1.0500 1.0500 0.0000 0.0810
0.0466
0.6240
MDA-MB-415
HR+
Luminal
TCS PIM-1 1
Pim kinase
PIM
12333.135
uM
inf
inf
1.0500 1.0500 0.0000 0.0098
0.0000
0.4305
MDA-MB-436
TNBC
Basal B
PD184352
MEK
MAPK
7898.029
uM
inf
inf
1.0500 1.0500 0.0000 0.0820
0.0614
0.7130
BT-20
TNBC
Basal A
Pemetrexed
TYMS/DHFR/GARFT
TYMS
5904.095
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.6537
Hs 578T
TNBC
Basal B
Sirolimus
MTOR
MTOR
7474.069
uM
inf
inf
1.0500 1.0500 0.0000 -0.0115
-0.0565
2.5606
MX1
Unknown
Unknown
PS-1145
IKK
NFKB
7523.065
uM
inf
inf
1.0500 1.0500 0.0000 -0.0407
-9.0127
0.7668
Hs 578T
TNBC
Basal B
Triciribine
AKT
AKT
7472.074
uM
inf
inf
1.0500 1.0500 0.0000 0.0523
-0.0595
1.5922
Hs 578T
TNBC
Basal B
GSK1838705A
IGF1R
RTK
7475.091
uM
inf
inf
1.0500 1.0500 0.0000 -0.0020
0.1302
2.6839
MCF7
HR+
Luminal
GW-5074
CRAF
MAPK
7493.088
uM
inf
inf
1.0500 1.0500 0.0000 -0.0387
-2.8472
1.0513
MDA-MB-436
TNBC
Basal B
LY294002
PI3K
PI3K
7898.029
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.7130
Hs 578T
TNBC
Basal B
Triciribine
AKT
AKT
7473.074
uM
inf
inf
1.0500 1.0500 0.0000 -0.0187
-0.0877
2.5364
Hs 578T
TNBC
Basal B
Methotrexate
DHFR
Metabolism
7475.084
uM
inf
inf
1.0500 1.0500 0.0000 -0.0415
-7.3003
2.7804
MCF 10F
NM
-
Cetuximab
EGFR
ErbB
7872.042
uM
inf
inf
1.0500 1.0500 0.0000 0.0054
-0.0002
1.3632
HCC3153
TNBC
Basal A
PS-1145
IKK
NFKB
7467.065
uM
inf
inf
1.0500 1.0500 0.0000 -0.0386
-3.7264
1.2393
HCC38
TNBC
Basal B
Trametinib
MEK
MAPK
9028.05
uM
inf
inf
1.0500 1.0500 0.0000 -0.0399
-2.6337
0.9299
HCC3153
TNBC
Basal A
GW843682X
PLK
PLK
10577.139
uM
inf
inf
1.0500 1.0500 0.0000 -0.0263
-0.5932
0.9234
MDA-MB-134-VI
HR+
Luminal
Cetuximab
EGFR
ErbB
10077.026
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.3999
EFM-192B
HER2amp
Luminal
Ribavirin
15288.211
uM
inf
inf
1.0500 1.0500 0.0000 -0.0002
-0.0013
0.9250
SUM1315MO2
TNBC
Basal B
Nilotinib
ABL
nRTK
10875.145
uM
inf
inf
1.0500 1.0500 0.0000 -0.0427
-3.3446
0.7643
MCF 10F
NM
-
FTase Inhibitor I
Ftase
MAPK
12254.154
uM
inf
inf
1.0500 1.0500 0.0000 -0.0451
-13.9008
1.6307
MDA-MB-415
HR+
Luminal
Methotrexate
DHFR
Metabolism
7512.084
uM
inf
inf
1.0500 1.0500 0.0000 -0.0491
-524.0720
0.7511
HCC2185
TNBC
Luminal
(Z)-4-Hydroxytamoxifen
ESR1
9420.132
uM
inf
inf
1.0500 1.0500 0.0000 0.0075
-0.0001
0.3309
MDA-MB-175-VII
HR+
Luminal
Cetuximab
EGFR
ErbB
7884.018
uM
inf
inf
1.0500 1.0500 0.0000 -0.0500
-inf
0.6074
MDA-MB-453
TNBC
Luminal
Cetuximab
EGFR
ErbB
9723.124
uM
inf
inf
1.0500 1.0500 0.0000 -0.0369
-1.9688
0.9827